DrGiancarlo Pascali

Internationally renowned leader in radiopharmaceutical sciences, in particular, for the research and development of new tracers, radiochemical methods and automation strategies. Activities are focused on the use of cyclotron produced nuclides, but extend also to reactor and generator produced ones, as well as on-demand synthetic chemistry. He is one of the pioneers in the use of microfluidic techniques in radiochemical processes.

Scholar profile

Giancarlo obtained his degree in Chemistry from the University of Pisa (Italy, 2001) and his PhD in "Innovative Biomedical Technologies" from the University of Lecce (Italy, 2004). During PhD, he worked at IFC-CNR (Pisa, Italy) and at NIH (Bethesda, MD, USA), under the supervision of Piero A. Salvadori and William C. Eckelman, studying novel radiolabelling methods for PET tracers. He then worked in the Clinical Chemistry environment (managing toxicology analysis laboratory, 2004-2008, University of Pisa) before returning to work in the radiochemistry field. He was Key Scientist for the EU funded "Radiochemistry On Chip" project (2008-2011) and worked as Staff Scientist at IFC-CNR (2008-2013, Pisa, Italy). During these years, he also worked in GMP facilities for the production of PET radiopharmaceuticals (Milan, Pisa), covering also the role of QC Manager. In 2013 Giancarlo moved to ANSTO in Australia, in the role of Radiochemistry Team Leader at the Camperdown cyclotron site; in 2020 he has been appointed Conjoint Associate Professor at the School of Chemistry in UNSW (Sydney) and holds Adjunct appointments at USyd.
Giancarlo is part of the Editorial board of several journals (Nuclear Medicine and Biology, Contrast Media & Molecular Imaging, Current Radiopharmaceuticals) and has covered and currently covers leading roles into several Scientific societies, such as: ANZSNM (RPS Chair, Executive board, SEC), ARTnet (Executive board), ASMI (President, Treasurer), SRS (current Director at Large, iSRS2025 Chair).